Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 3,657 | 4,427 | 3,642 | 3,873 | 3,661 |
| Operating Income | -3,657 | -4,427 | -3,642 | -3,873 | -3,661 |
| Interest Expense | 4 | 4 | 4 | 4 | 4 |
| Other Income | 12 | 25 | 14 | 2 | 818 |
| Pre-tax Income | -3,650 | -4,406 | -3,632 | -3,875 | -2,847 |
| Net Income Continuous | -3,650 | -4,406 | -3,632 | -3,875 | -2,847 |
| Net Income | $-3,650 | $-4,406 | $-3,632 | $-3,875 | $-2,847 |
| EPS Basic Total Ops | -3.75 | -5.00 | -5.00 | -5.50 | -4.00 |
| EPS Basic Continuous Ops | -3.92 | -5.01 | -4.91 | -5.45 | -3.95 |
| EPS Diluted Total Ops | -3.75 | -5.00 | -5.00 | -5.50 | -4.00 |
| EPS Diluted Continuous Ops | -3.92 | -5.01 | -4.91 | -5.45 | -3.95 |
| EBITDA(a) | $-3,657 | $-4,427 | $-3,642 | $-3,872 | $-3,661 |